Department of Pharmaceutical Sciences, College of Pharmacy, Mercer University Health Sciences Center, Mercer University, Atlanta, GA 30341, United States.
Department of Pharmaceutical Sciences, College of Pharmacy, Mercer University Health Sciences Center, Mercer University, Atlanta, GA 30341, United States.
Biochem Pharmacol. 2018 Apr;150:170-180. doi: 10.1016/j.bcp.2018.02.011. Epub 2018 Feb 13.
A dietary influence on cancer progression has been evident for many decades, and dietary fatty acids, particularly long chain mono- and polyunsaturated fatty acids, have been shown to play significant roles in influencing growth of a variety of human cancers. The discovery of the family of cell-surface free-fatty acid receptors, which include the long-chain fatty acid receptors FFA1 and FFA4, suggest that many of the effects of dietary fats could be receptor-mediated. FFA4 is ubiquitously expressed and has recently been shown to modulate a variety of important anti-inflammatory and metabolic processes. Since FFA4 is currently an attractive drug target for treatment of metabolic disorders such as diabetes and obesity, understanding its role in cancer progression is critical towards the drug discovery process. In this research update, the current body of knowledge on the role of this receptor in regulating cancer cell proliferation, migration, and invasion, as well as in vivo tumorigenesis is reviewed.
几十年来,饮食对癌症进展的影响已经很明显,膳食脂肪酸,特别是长链单不饱和和多不饱和脂肪酸,已被证明在影响多种人类癌症的生长中发挥重要作用。细胞表面游离脂肪酸受体家族的发现,包括长链脂肪酸受体 FFA1 和 FFA4,表明许多膳食脂肪的作用可能是受体介导的。FFA4 广泛表达,最近已被证明可调节多种重要的抗炎和代谢过程。由于 FFA4 目前是治疗糖尿病和肥胖等代谢紊乱的有吸引力的药物靶点,因此了解其在癌症进展中的作用对于药物发现过程至关重要。在本研究更新中,回顾了该受体在调节癌细胞增殖、迁移和侵袭以及体内肿瘤发生中的作用的现有知识体系。